SI1487541T1 - Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja - Google Patents
Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝iljaInfo
- Publication number
- SI1487541T1 SI1487541T1 SI200331457T SI200331457T SI1487541T1 SI 1487541 T1 SI1487541 T1 SI 1487541T1 SI 200331457 T SI200331457 T SI 200331457T SI 200331457 T SI200331457 T SI 200331457T SI 1487541 T1 SI1487541 T1 SI 1487541T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inhibitors
- prevention
- treatment
- peripheral vascular
- vascular diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02100290 | 2002-03-22 | ||
| PCT/EP2003/050061 WO2003080104A2 (en) | 2002-03-22 | 2003-03-13 | Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| EP03714958A EP1487541B1 (en) | 2002-03-22 | 2003-03-13 | Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1487541T1 true SI1487541T1 (sl) | 2009-02-28 |
Family
ID=28051827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331457T SI1487541T1 (sl) | 2002-03-22 | 2003-03-13 | Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US9592267B2 (sl) |
| EP (1) | EP1487541B1 (sl) |
| JP (1) | JP4885424B2 (sl) |
| KR (1) | KR20050004809A (sl) |
| CN (1) | CN100540058C (sl) |
| AR (1) | AR039103A1 (sl) |
| AT (1) | ATE414556T1 (sl) |
| AU (1) | AU2003219162B2 (sl) |
| BR (1) | BRPI0308663B8 (sl) |
| CA (1) | CA2478855C (sl) |
| CY (1) | CY1108748T1 (sl) |
| DE (1) | DE60324777D1 (sl) |
| DK (1) | DK1487541T3 (sl) |
| EA (1) | EA008495B1 (sl) |
| ES (1) | ES2314191T3 (sl) |
| HK (1) | HK1075422A1 (sl) |
| HR (1) | HRP20040758B1 (sl) |
| IL (2) | IL164211A0 (sl) |
| ME (1) | ME00548B (sl) |
| MX (1) | MXPA04009135A (sl) |
| NO (1) | NO336226B1 (sl) |
| PL (1) | PL207303B1 (sl) |
| PT (1) | PT1487541E (sl) |
| RS (1) | RS51755B (sl) |
| SI (1) | SI1487541T1 (sl) |
| UA (1) | UA80275C2 (sl) |
| WO (1) | WO2003080104A2 (sl) |
| ZA (1) | ZA200407022B (sl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
| TWI335336B (sl) * | 2000-02-10 | 2011-01-01 | Abbott Gmbh & Co Kg | |
| KR20050004809A (ko) | 2002-03-22 | 2005-01-12 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 말초 맥관 질환 치료 및/또는 예방에 사용되는 ｉｌ-18저해제 |
| US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| IL159670A0 (en) * | 2003-12-31 | 2004-06-01 | Yeda Res & Dev | Use of il-18 binding protein in inflammations |
| ES2429443T3 (es) * | 2004-04-19 | 2013-11-14 | Strategic Science & Technologies, Llc | Suministro transdérmico de sustancias beneficiosas efectuado mediante un entorno de fuerza iónica elevada |
| US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
| DK1885753T3 (da) | 2005-06-03 | 2011-10-03 | Ares Trading Sa | Fremstilling af rekombinant II-18-proteiner |
| DK1891088T3 (da) | 2005-06-10 | 2012-01-30 | Ares Trading Sa | Fremgangsmåde til rensning af et IL-18-bindende protein |
| US8753690B2 (en) | 2008-02-27 | 2014-06-17 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
| EP2567692B1 (en) | 2008-02-27 | 2016-04-06 | Biomet Biologics, LLC | Use of a device for obtaining interleukin-1 receptor antagonist rich solutions |
| WO2010151241A1 (en) | 2009-06-24 | 2010-12-29 | Strategic Science & Technologies, Llc | Topical composition containing naproxen |
| US8604081B2 (en) | 2009-06-24 | 2013-12-10 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
| US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| JP5844258B2 (ja) | 2009-08-27 | 2016-01-13 | バイオメット、バイオロジクス、リミテッド、ライアビリティー、カンパニーＢｉｏｍｅｔ Ｂｉｏｌｏｇｉｃｓ， Ｌｌｃ | インターロイキン−１受容体アンタゴニストの生産のための植込み型装置 |
| CA2774999A1 (en) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| AR082518A1 (es) | 2010-08-25 | 2012-12-12 | Hoffmann La Roche | Anticuerpos contra il-18r1 y usos de los mismos |
| CN103442723A (zh) | 2010-12-29 | 2013-12-11 | 战略科学与技术有限责任公司 | 治疗变态反应和其它适应症的系统和方法 |
| PT2658551T (pt) | 2010-12-29 | 2020-07-24 | Strategic Science & Tech Llc | Tratamento da disfunção erétil e outras indicações |
| JOP20200308A1 (ar) | 2012-09-07 | 2017-06-16 | Novartis Ag | جزيئات إرتباط il-18 |
| US9878011B2 (en) | 2013-03-15 | 2018-01-30 | Biomet Biologics, Llc | Treatment of inflammatory respiratory disease using biological solutions |
| US9758806B2 (en) | 2013-03-15 | 2017-09-12 | Biomet Biologics, Llc | Acellular compositions for treating inflammatory disorders |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| EP3074507B1 (en) | 2013-11-26 | 2022-01-05 | Biomet Biologics, LLC | Methods of mediating macrophage phenotypes |
| US10441635B2 (en) | 2014-11-10 | 2019-10-15 | Biomet Biologics, Llc | Methods of treating pain using protein solutions |
| MX2017010919A (es) * | 2015-03-05 | 2017-12-07 | Ab2 Bio Sa | Proteina de union il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias. |
| US9763800B2 (en) | 2015-03-18 | 2017-09-19 | Biomet C. V. | Implant configured for hammertoe and small bone fixation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877197A (en) * | 1996-12-16 | 1999-03-02 | Karanewsky; Donald S. | C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| KR100537558B1 (ko) * | 1998-09-01 | 2005-12-19 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | 인터류킨-18 결합 단백질 |
| EP1101772B1 (en) * | 1999-11-16 | 2009-01-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Antibody specific to interleukin 18 precursor |
| RS50926B (sr) * | 2000-05-05 | 2010-08-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Upotreba il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze |
| PE20011350A1 (es) * | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| KR20050004809A (ko) | 2002-03-22 | 2005-01-12 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 말초 맥관 질환 치료 및/또는 예방에 사용되는 ｉｌ-18저해제 |
-
2003
- 2003-03-13 KR KR10-2004-7014401A patent/KR20050004809A/ko active Search and Examination
- 2003-03-13 MX MXPA04009135A patent/MXPA04009135A/es active IP Right Grant
- 2003-03-13 WO PCT/EP2003/050061 patent/WO2003080104A2/en active Application Filing
- 2003-03-13 US US10/508,574 patent/US9592267B2/en active Active
- 2003-03-13 SI SI200331457T patent/SI1487541T1/sl unknown
- 2003-03-13 AU AU2003219162A patent/AU2003219162B2/en not_active Expired
- 2003-03-13 JP JP2003577930A patent/JP4885424B2/ja not_active Expired - Lifetime
- 2003-03-13 PL PL372398A patent/PL207303B1/pl unknown
- 2003-03-13 CN CNB038116510A patent/CN100540058C/zh not_active Expired - Lifetime
- 2003-03-13 DE DE60324777T patent/DE60324777D1/de not_active Expired - Lifetime
- 2003-03-13 BR BRPI0308663A patent/BRPI0308663B8/pt not_active IP Right Cessation
- 2003-03-13 IL IL16421103A patent/IL164211A0/xx unknown
- 2003-03-13 EA EA200401240A patent/EA008495B1/ru not_active IP Right Cessation
- 2003-03-13 ME MEP-2008-679A patent/ME00548B/me unknown
- 2003-03-13 CA CA2478855A patent/CA2478855C/en not_active Expired - Lifetime
- 2003-03-13 UA UA20041008590A patent/UA80275C2/uk unknown
- 2003-03-13 RS YU81504A patent/RS51755B/en unknown
- 2003-03-13 AT AT03714958T patent/ATE414556T1/de active
- 2003-03-13 DK DK03714958T patent/DK1487541T3/da active
- 2003-03-13 EP EP03714958A patent/EP1487541B1/en not_active Expired - Lifetime
- 2003-03-13 ES ES03714958T patent/ES2314191T3/es not_active Expired - Lifetime
- 2003-03-13 PT PT03714958T patent/PT1487541E/pt unknown
- 2003-03-21 AR ARP030101000A patent/AR039103A1/es not_active Application Discontinuation
-
2004
- 2004-08-23 HR HRP20040758AA patent/HRP20040758B1/hr not_active IP Right Cessation
- 2004-09-02 ZA ZA200407022A patent/ZA200407022B/en unknown
- 2004-09-22 IL IL164211A patent/IL164211A/en active IP Right Grant
- 2004-10-20 NO NO20044459A patent/NO336226B1/no not_active IP Right Cessation
-
2005
- 2005-11-01 HK HK05109693.6A patent/HK1075422A1/xx not_active IP Right Cessation
-
2009
- 2009-02-05 CY CY20091100132T patent/CY1108748T1/el unknown
-
2010
- 2010-06-01 US US12/791,052 patent/US9566313B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1487541T1 (sl) | Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja | |
| AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
| HK1089376A1 (en) | Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions | |
| EP1455778A4 (en) | METHODS OF TREATING PERIPHERAL NEUROVASCULAR MALAYS | |
| HK1086488A1 (en) | Compound and use thereof for the treatment of cancer | |
| EP1489915A4 (en) | TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS | |
| AU2003223579A8 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
| AU2003229923A1 (en) | Curcumin for the prevention and/or treatment of tissue damage | |
| ZA200208228B (en) | Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis | |
| EP1604664A4 (en) | MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE | |
| ZA200800981B (en) | Use of SDF-1 for the treatment and/or prevention of neurological diseases | |
| HK1079220A1 (en) | Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases cd83 | |
| HRP20030609A2 (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
| EP1624786A4 (en) | METHOD FOR THE TREATMENT AND PREVENTION OF ILLNESSES OF BIOLOGICAL CHANNELS | |
| IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2003222252A8 (en) | Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases | |
| EP1551456A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RENAL DISEASES | |
| EP1412360A4 (en) | COMBINATION THERAPY WITH A SODM AND A CORTICOSTEROID FOR THE PREVENTION AND / OR TREATMENT OF FLAMMABLE DISEASES | |
| EP1669085A4 (en) | THERAPEUTIC AGENT FOR THE PREVENTION AND / OR TREATMENT OF ALZHEIMER'S DISEASE | |
| AU2003294697A8 (en) | Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain | |
| AU2003209489A1 (en) | Medical use of captopril for the treatment and prophylaxis of cancer | |
| IL151658A0 (en) | Methods and compositions for the treatment or prevention of cardiovascular diseases | |
| AU2003255662A1 (en) | Device for prevention and treatment of vascular disorders | |
| AU2003201641A8 (en) | Treatment and diagnosis of af4-dependant diseases |